Medicare Advisers Endorse Patient Reported Outcomes For CAR-T With Caveats

The US Medicare Evidence Development and Coverage Advisory Committee supported the use of some patient reported outcomes (PROs) to improve patient care for seniors at its Aug. 22 meeting. But members also raised questions about how PROs should fit into Medicare coverage decisions for CAR-T therapy.

The meeting was convened by the Centers for Medicare and Medicaid Services to inform a Medicare national coverage determination analysis on chimeric antigen receptor T-cell (CAR-T) treatments